Camurus : AGM minutes 2024 - MarketScreener marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.
/PRNewswire/ Oncopeptides AB (publ.) (Nasdaq Stockholm: ONCO), a biotech company focused on research and development of therapies for difficult-to-treat.
STOCKHOLM, Jan. 4, 2023 /PRNewswire/ Oncopeptides AB (publ.) (Nasdaq Stockholm: ONCO), a biotech company focused on research and development of therapies for difficult-to-treat hematological
The drug was granted an accelerated approval, but a confirmatory phase 3 trial raised concerns about safety after showing higher mortality than in the comparator arm.